SCHEMBL28792014

SCHEMBL28792014

O=C(O)c1coc(NC(F)(F)F)n1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 5/20 0.34
NLRP3 Q96P20 4/20 0.33
CES1 P23141 1/20 0.33
HDAC8 Q9BY41 4/20 0.33
HDAC6 Q9UBN7 4/20 0.33
ALOX15 P16050 2/20 0.32
TSHR P16473 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ACMSD Q8TDX5 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
HIF1A Q16665 1/20 0.31
ASPH Q12797 1/20 0.31
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31
FBP1 P09467 1/20 0.30
ALDH1A1 P00352 1/20 0.30
DAGLA Q9Y4D2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25518364 0.76 HDAC1 (0.36) HDAC1NLRP3CES1HDAC8HDAC6
SCHEMBL18629308 0.76 HDAC1 (0.40) HDAC1NLRP3CES1HDAC8HDAC6
SCHEMBL15053076 0.73 KDM4E (0.46) HDAC1CES1ALOX15TSHRKDM4E
SCHEMBL2481569 0.72 ASPH (0.37) HDAC1CES1HDAC8HDAC6ALOX15
SCHEMBL23021251 0.71 HDAC1 (0.37) HDAC1NLRP3CES1HDAC8HDAC6
SCHEMBL3370259 0.71 ELANE (0.37) HDAC1NLRP3CES1HDAC8HDAC6
SCHEMBL3539633 0.71 ELANE (0.37) HDAC1NLRP3CES1HDAC8HDAC6
SCHEMBL554753 0.70 KLKB1 (0.50) HDAC1CES1HDAC8HDAC6ALOX15
SCHEMBL3347980 0.70 MMP2 (0.43) HDAC1NLRP3
SCHEMBL1660252 0.70 IDH2 (0.51) TDP1HIF1APTGS1PTGS2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102137851-A Novel compounds as vanilloid receptor antagonists, isomers thereof or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the same AMOREPACIFIC CORP 2011-07-27 CN disclosed